Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 88 | 170 | 202 | 141 | 135 |
| Cost of Goods | 128 | 31 | 42 | N/A | 850 |
| Gross Profit | -40 | 139 | 160 | 141 | -715 |
| Operating Expenses | 11,752 | 19,942 | 32,118 | 20,064 | 18,973 |
| Operating Income | -11,664 | -19,772 | -31,916 | -19,923 | -18,838 |
| Interest Expense | 812 | 585 | 0 | 0 | 67 |
| Other Income | -1,482 | 3,037 | 2,954 | 478 | -222 |
| Pre-tax Income | -13,958 | -17,320 | -28,962 | -19,445 | -19,127 |
| Net Income Continuous | -13,958 | -17,320 | -28,962 | -19,445 | -19,127 |
| Net Income | $-13,958 | $-17,320 | $-28,962 | $-19,445 | $-19,127 |
| EPS Basic Total Ops | -8.62 | -30.92 | -60.00 | -40.00 | -40.00 |
| EPS Basic Continuous Ops | -8.62 | -30.92 | -59.61 | -40.47 | -40.40 |
| EPS Diluted Total Ops | -8.62 | -30.92 | -60.00 | -40.00 | -40.00 |
| EPS Diluted Continuous Ops | -8.62 | -30.92 | -59.61 | -40.47 | -40.40 |
| EPS Diluted Before Non-Recurring Items | N/A | -31.00 | -60.00 | -40.00 | -40.00 |
| EBITDA(a) | $-9,764 | $-19,177 | $-31,664 | $-19,667 | $-18,016 |